Moxifloxacin

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.

INDICATIONS

Acute exacerbations of chronic bronchitis (AECB)
Acute bacterial sinusitis (ABS)
- Use for AECB and ABS indications should be avoided for routine use due recent FDA warning (Black Box warning) regarding serious and potentially permanent side effects (tendonitis and tendon rupture, peripheral neuropathy, and CNS side effects).
- FDA safety warning regarding fluoroquinolone use
Community-acquired pneumonia
Skin and skin structure infections (including complicated)
Complicated intra-abdominal infections
Bacterial conjunctivitis (ophthalmic drops)

Treatment of M. tuberculosis including MDR and XDR-TB (in combination with other agents)
Treatment of MAI and other non-TB mycobacterial infections (in combination with other agents)
Alternative therapy for treatment of S. pneumoniae and H. influenzae meningitis in patients who have severe penicillin allergies.

There's more to see -- the rest of this topic is available only to subscribers.